These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36411094)

  • 1. Evolution of a Transplant Surgery Advanced Practice Provider Practice Model in the Care of High-Acuity Liver Transplant Recipients: A Single-Center Experience.
    Mahaffey JJ; Selim MA; Kristbaum KA; Mayer J; Martin A; Durazo FA; Hong JC
    Transplant Proc; 2022 Dec; 54(10):2621-2626. PubMed ID: 36411094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience.
    Zimmerman MA; Selim M; Kim J; Saeian K; Cinquegrani MP; Connolly L; Woehlck HJ; Lauer KK; Hong JC
    Transplant Proc; 2018 Dec; 50(10):3544-3548. PubMed ID: 30577234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database.
    Gupta M; Bahirwani R; Levine MH; Malik S; Goldberg D; Reddy KR; Shaked A
    Pediatr Transplant; 2015 Mar; 19(2):153-63. PubMed ID: 25495572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
    Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.
    Parikh A; Washburn KW; Matsuoka L; Pandit U; Kim JE; Almeda J; Mora-Esteves C; Halff G; Genyk Y; Holland B; Wilson DJ; Sher L; Koneru B
    Liver Transpl; 2015 Sep; 21(9):1160-8. PubMed ID: 25991395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience.
    Tun-Abraham ME; Wanis K; Garcia-Ochoa C; Sela N; Sharma H; Al Hasan I; Quan D; Al-Judaibi B; Levstik M; Hernandez-Alejandro R
    Can J Surg; 2019 Feb; 62(1):44-51. PubMed ID: 30484989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Liver Transplantation for Patients Over 60 Years Old: A Single-Center Experience.
    Akdur A; Karakaya E; Ayvazoglu Soy HE; Yarbug Karakayalı F; Moray G; Haberal M
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):31-38. PubMed ID: 35384805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of adult liver re-transplant patients in the model for end-stage liver disease era: is it time to reconsider its indications?
    Montenovo MI; Hansen RN; Dick AA
    Clin Transplant; 2014 Oct; 28(10):1099-104. PubMed ID: 25041109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis.
    Conzen KD; Vachharajani N; Collins KM; Anderson CD; Lin Y; Wellen JR; Shenoy S; Lowell JA; Doyle MB; Chapman WC
    HPB (Oxford); 2015 Mar; 17(3):251-7. PubMed ID: 25322849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes.
    Lee TC; Dhar VK; Hoehn RS; Wima K; Kim Y; Ertel AE; Patel SH; Shah SA
    Surgery; 2019 Dec; 166(6):1135-1141. PubMed ID: 31375321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplant Outcomes in a Newly Started Program.
    Sultanaliev T; Zhexembayev A; Mukazhanov A; Zharkymbekov B; Kuttymuratov G; Spatayev Z; Ibrayev B; Yesmembetov K; Ashimkhanova A; Asykbayev M
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():120-2. PubMed ID: 26640930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.